New combo attack on lung cancer in the brain
NCT ID NCT06248606
Summary
This study is testing whether combining a targeted drug (adagrasib) with precise radiation to the brain (stereotactic radiosurgery) can better control lung cancer that has spread to the brain. It is for up to 30 adults with a specific type of advanced lung cancer (KRAS G12C-mutated NSCLC) who have untreated brain tumors. The main goal is to see if this combination stops the brain tumors from growing for at least 3 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Virginia Health System
RECRUITINGCharlottesville, Virginia, 22908, United States
Contact Email: •••••@•••••
Contact
-
Virginia Commonwealth University
RECRUITINGRichmond, Virginia, 23298, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.